Factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcome

Fertility and Sterility

Volumn 94, Issue 4, 2010, Pages 1399-1404

  Luke, Barbara ^a   Brown, Morton B ^b   Morbeck, Dean E ^c   Hudson, Susan B ^c   Coddington III, Charles C ^c   Stern, Judy E ^d  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c MAYO CLINIC   (United States)

^d DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

adverse pregnancy outcomes; ART; multiple gestations; Ovarian hyperstimulation syndrome

Indexed keywords

ADULT; ARTICLE; CAUCASIAN; CLINICAL EVALUATION; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; EMBRYO TRANSFER; ENDOMETRIOSIS; FEMALE; FEMALE INFERTILITY; HIGH RISK PREGNANCY; HISPANIC; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE INFERTILITY; MATERNAL AGE; MEDICAL SOCIETY; NEGRO; OVARIAN RESERVE; OVARY HYPERSTIMULATION; OVARY INSUFFICIENCY; PREGNANCY; PREGNANCY OUTCOME; PREMATURITY; PRIORITY JOURNAL; RISK FACTOR; STILLBIRTH; TREATMENT OUTCOME; UTERINE TUBE; COMPLICATION; ETHNIC GROUP; ETHNOLOGY; EVALUATION STUDY; NEWBORN; OVARIAN HYPERSTIMULATION SYNDROME; PREGNANCY RATE; STATISTICS AND NUMERICAL DATA;

ADULT; COHORT STUDIES; ETHNIC GROUPS; FEMALE; HUMANS; INFANT, NEWBORN; LIVE BIRTH; OVARIAN HYPERSTIMULATION SYNDROME; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; REPRODUCTIVE TECHNIQUES, ASSISTED; RISK FACTORS; TREATMENT OUTCOME;

EID: 77956187823     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.05.092     Document Type: Article

References (35)

1. P.E. Levi-Setti, M. Cavagna, A. Baggiani, E. Zannoni, G.V. Colombo, and V. Liprandi FSH and LH together in ovarian stimulation Eur J Obstet Gyn 115 2004 S34 S39
2. C.C. Beerendonk, P.A. van Dop, D.D. Braat, and J.M. Merkus Ovarian hyperstimulation syndrome: facts and fallacies Obstet Gynecol Survey 53 1998 439 449
3. M. Aboulghar Prediction of ovarian hyperstimulation syndrome (OHSS): estradiol level has an important role in the prediction of OHSS Hum Reprod 18 2003 1140 1141
4. A. Raziel, S. Friedler, M. Schachter, D. Strassburger, E. Mordechai, and R. Ron-El Increased early pregnancy loss in IVF patients with severe ovarian hyperstimulation syndrome Hum Reprod 17 2002 107 110
5. H. Binder, R. Dittrich, F. Einhaus, J. Krieg, A. Muller, and R. Strauss Update on ovarian hyperstimulation syndrome: Part 1 - incidence and pathogenesis Int J Fertil Womens Med 52 2007 11 26
6. A. Wiser, J. Levron, D. Kreizer, R. Achiron, A. Shrim, and E. Schiff Outcome of pregnancies complicated by severe ovarian hyperstimulation syndrome (OHSS): a follow-up beyond the second trimester Hum Reprod 20 2005 910 914
7. J.G. Schenker Clinical aspects of ovarian hyperstimulation syndrome Eur J Obstet Gynecol 85 1999 13 20
8. The Practice Committee of the American Society for Reproductive Medicine Ovarian hyperstimulation syndrome Fertil Steril 86 2006 S178 S183
9. M. Davis, and R. Kennedy Ovarian hyperstimulation syndrome: aetiology, prevention, and management Rev Gynaecol Perinat Pract 6 2006 26 32
10. C.M. Andraus, S. Abdelmassih, C.C. Rocha, C. Carizza, V. Abdelmassih, and R. Abdelmassih Influence of the ovarian hyperstimulation syndrome (OHSS) in embryo quality and in implantation and pregnancy rates Fertil Steril 90 Suppl 1 2008 S132
11. E.G. Papanikolaou, C. Pozzobon, E.M. Kolibianakis, M. Camus, H. Tournaye, and H.M. Fatemi Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropins-releasing hormone antagonist in vitro fertilization cycles Fertil Steril 85 2006 112 120
12. R. Michaelson-Cohen, G. Altarescu, R. Beller, T. Halevy-Shalem, and T. Eldar-Geva Does elevated human chorionic gonadotropins alone trigger spontaneous ovarian hyperstimulation syndrome? Fertil Steril 90 2008 1869 1874
13. Y. Abramov, U. Elchalal, and J.G. Schenker Obstetric outcome of in vitro fertilized pregnancies complicated by severe ovarian hyperstimulation syndrome: a multicenter study Fertil Steril 70 1998 1070 1076
14. E.G. Papanikolaou, H. Tournaye, W. Verpoest, M. Camus, V. Vernaeve, and A. Van Steirteghem Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile Hum Reprod 20 2005 636 641
15. M.A. Aboulghar, R.T. Mansour, G.I. Serour, A.M. Ramzy, and Y.M. Amin Oocyte quality in patients with severe ovarian hyperstimulation syndrome Fertil Steril 68 1997 1017 1021
16. Y. Abramov, M. Fatum, D. Abrahamov, and J.G. Schenker Hydroxyethylstarch versus human albumin for the treatment of severe ovarian hyperstimulation syndrome: a preliminary report Fertil Steril 75 2001 1228 1230
17. C. Alvarez, I. Alonso-Muriel, G. Garcia, J. Crespo, J. Bellver, and C. Simon Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study Hum Reprod 22 2007 3210 3214
18. K. Chung, C. Coutifaris, R. Chalian, K. Lin, S.J. Ratcliffe, and A.J. Castelbaum Factors influencing adverse perinatal outcomes in pregnancies achieved through use of in vitro fertilization Fertil Steril 86 2006 1634 1641
19. P.O. Dale, T. Tanbo, and T. Abyholm In-vitro fertilization in infertile women with the polycystic ovarian syndrome Hum Reprod 6 1991 238 241
20. J.E. Nichols Jr., H.L. Higdon 3rd, M.M.T. Crane, and W.R. Boone Comparison of implantation and pregnancy rates in African American and white women in an assisted reproductive technology practice Fertil Steril 76 2001 80 84
21. K. Bendikson, D.W. Cramer, A. Vitonis, and M.D. Hornstein Ethnic background and in vitro fertilization outcomes Int J Gynaecol Obstet 88 2005 342 346
22. D.B. Seifer, L.M. Frazier, and D.A. Grainger Disparity in assisted reproductive technologies outcomes in black women compared with white women Fertil Steril 90 2008 1701 1710
23. V.Y. Fujimoto, B. Luke, M.B. Brown, T. Jain, A. Armstrong, and D.A. Grainger Racial and ethnic disparities in assisted reproductive technology outcomes in the United States Fertil Steril 2008 Dec 10 [Epub ahead of print]
24. K. Kosaka, H. Fujiwara, S. Yoshioka, and S. Fujii Vascular endothelial growth factor production by circulating immune cells is elevated in ovarian hyperstimulation syndrome Hum Reprod 22 2007 1647 1651
25. A. Pellicer, C. Albert, A. Mercader, F. Bonilla-Musoles, J. Remohi, and C. Simon The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor Fertil Steril 71 1999 482 489
26. E. Geva, J.B. Lessing, L. Lerner-Geva, F. Azem, I. Yovel, and A. Amit Elevated levels of interleukin-6 in the follicular fluid at the time of oocyte retrieval for in vitro fertilization may predict the development of early-form ovarian hyperstimulation syndrome Fertil Steril 68 1997 133 137
27. V. Barak, U. Elchalal, M. Edelstein, I. Kalickman, A. Lewin, and Y. Abramov Interleukin-18 levels correlate with severe ovarian hyperstimulation syndrome Fertil Steril 82 2004 415 420
28. R.S. Morris, and R.J. Paulson Increased angiotensin-converting enzyme activity in a patient with severe ovarian hyperstimulation syndrome Fertil Steril 71 1999 562 563
29. A. Enskog, L. Nilsson, and M. Brannstrom Peripheral blood concentrations of inhibin B are elevated during gonadotrophin stimulation in patients who later develop ovarian OHSS and inhibin A concentrations are elevated after OHSS onset Hum Reprod 15 2000 532 538
30. C. Daelemans, G. Smits, V. de Maertelaer, S. Costagliola, Y. Englert, and G. Vassart Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism J Clin Endocrinol Metab 89 2004 6310 6315
31. G. Meduri, A. Bachelot, M.P. Cocca, C. Vasseur, P. Rodien, and F. Kuttenn Molecular pathology of the FSH receptor: new insights into FSH physiology Mol Cell Endocrinol 282 2008 130 142
32. H. Binder, R. Dittrich, I. Hager, A. Muller, S. Oeser, and M.W. Beckmann Association of FSH receptor and CYP19A1 gene variations with sterility and ovarian hyperstimulation syndrome Reproduction 135 2008 107 116
33. A. D'Angelo, and N. Amso Embryo freezing for preventing ovarian hyperstimulation syndrome Cochrane Database Syst Rev 2007 CD002806
34. B. Urman, B. Balaban, and K. Yakin Impact of fresh-cycle variables on the implantation potential of cryopreserved-thawed human embryos Fertil Steril 87 2007 310 315
35. N. Rollene, M. Amols, S. Hudson, and C. Coddington Treatment of ovarian hyperstimulation syndrome utilizing a dopamine agonist and gonadotropin releasing hormone antagonist Fertil Steril 91 S 2009 S14